FDA DEVICE FACTS
AquaBeam Robotic System
Procept Biorobotics, Corporation
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The intended use of the subject device is identical to the intended use of the predicate device. The AQUABEAM Robotic System is intended for the resection and removal of prostate tissue in males suffering from lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia. Intended Patient Population The intended patient population of the subject device is identical to the intended use of the predicate device. The intended patient population is males suffering from LUTS resulting from benign prostatic hyperplasia (BPH). Intended Users The intended users of the subject device is identical to the intended use of the predicate device. The intended users are urologists and support staff who are trained and familiar with Transrectal Ultrasound (TRUS) and performing endoscopic surgical benign prostatic hyperplasia procedures and in recognizing and managing their complications. Technological Characteristics as Compared to the Predicate Device The technological characteristics of the AQUABEAM Robotic System such as design, material and chemical composition of patient contacting components and energy source remain equivalent to the predicate device, AQUABEAM System. The table below summarizes the comparison between the subject device and the predicate device -
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。